Skip to main content

Multiple Sclerosis

FDA Approvals, Multiple Sclerosis
Tyruko First Biosimilar for the Treatment of Relapsing Forms of Multiple Sclerosis
Read More
Pain, Multiple Sclerosis
Multiple Sclerosis: Systemic Challenges to Cost-Effective Care
David R. Weinstein, PhD; Gary M. Owens, MD; Ankit Gandhi, PharmD
Read More
Original Research, Practice Management, Multiple Sclerosis
Expenditure, Utilization, and Cost of Specialty Drugs for Multiple Sclerosis in the US Medicaid Population, 2008-2018
Zizi Elsisi, BPharm; Ana L. Hincapie, PhD; Jeff Jianfei Guo, BPharm, PhD
Stakeholder Perspective
Utilization Challenges of Drugs for Multiple Sclerosis in a Medicaid Population
James T. Kenney, RPh, MBA
Read More

Results 1 - 3 of 3